Novel isoforms of tau that lack the microtubule-binding domain

Journal of Neurochemistry

Volumn 90, Issue 2, 2004, Pages 340-351

  Luo, Min Hua ^a,b   Tse, Sze Wah ^a   Memmott, John ^a   Andreadis, Athena ^a,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Central South University   (China)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alternative splicing; Hippocampal localization; Neuroblastoma cells; Neuronal process; Tau truncated isoform variants

Indexed keywords

BINDING PROTEIN; ISOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DENTATE GYRUS; GENE OVEREXPRESSION; GENETIC STABILITY; GRANULAR CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PYRAMIDAL NERVE CELL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; EXONS; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; NEURONS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TAU PROTEINS; TRANSFECTION;

ANIMALIA; MAMMALIA;

EID: 3142704290     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02508.x     Document Type: Article

References (60)

1. Andreadis A., Nisson P., Kosik K. S. and Watkins P. (1993) The exon trapping assay partly discriminates against alternatively spliced exons. Nucl. Acids Res. 21, 2217-2221.
2. Bahr B. A. and Vicente J. S. (1998) Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain. J. Neuropathol. Exp. Neurol. 57, 111-121.
3. Billingsley M. L. and Kincaid R. L. (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323, 577-591.
4. Black M. M., Slaughter T., Moshiach S., Obrocka M. and Fischer I. (1996) Tau is enriched on dynamic microtubules in the distal region of growing axons. J. Neurosci. 16, 3601-3619.
5. Brandt R. L., Èger J. and Lee G. (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327-1340.
6. Cáceres A. and Kosik K. S. (1990) Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 343, 461-463.
7. Cáceres A., Potrebic S. and Kosik K. S. (1991) The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons. J. Neurosci. 11, 1515-1523.
8. Canu N., Dus L., Barbato C., Ciotti M. T., Brancolini C., Rinaldi A. M., Novak M., Cattaneo A., Bradbury A. and Calissano P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18, 7061-7074.
9. Chen J., Kanai Y., Cowan N. J. and Hirokawa N. (1992) Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360, 674-677.
10. Chung C. W., Song Y. H., Kim I. K. et al. (2001) Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis. 8, 162-172.
11. Clark L. N., Poorkaj P., Wszolek Z. et al. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl Acad. Sci. USA 95, 13103-13107.
12. Couchie D., Mavilia C., Georgieff I. S., Liem R. K., Shelanski M. L. and Nuñez J. (1992) Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl Acad. Sci. USA 89, 4378-4381.
13. D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V. M., Bird T. D. and Schellenberg G. D. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl Acad. Sci. USA 96, 5598-5603.
14. Dawson H. N., Ferreira A., Eyster M. V., Ghoshal N., Binder L. I. and Vitek M. P. (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 114, 1179-1187.
15. DiTella M., Feiguin F., Morfini G. and Caceres A. (1994) Microfilament-associated growth cone component depends upon Tau for its intracellular localization. Cell Motil. Cytoskeleton 29, 117-130.
16. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Cena V., Gallego C. and Comella J. X. (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75, 991-1003.
17. Fasulo L., Ugolini G., Visintin M., Bradbury A., Brancolini C., Verzillo V., Novak M. and Cattaneo A. (2000) The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75, 624-633.
18. Foulkes N. S. and Sassone-Corsi P. (1992) More is better: activators and repressors from the same gene. Cell 68, 411-414.
19. Frappier T. F., Georgieff I. S., Brown K. and Shelanski M. L. (1994) Tau regulation of microtubule-microtubule spacing and bundling. J. Neurochem. 63, 2288-2294.
20. Furukawa K., D'Souza I., Crudder C. H., Onodera H., Itoyama Y., Poorkaj P., Bird T. D. and Schellenberg G. D. (2000) Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism. Neuroreport 11, 57-60.
21. Gao. Q. S., Memmott J., Lafyatis R., Stamm S., Screaton G. and Andreadis A. (2000) Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J. Neurochem. 74, 490-500.
22. Garcia-Sierra F., Wischik C. M., Harrington C. R., Luna-Muñoz J. and Mena R. (2001) Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. J. Chem. Neuroanat. 22, 65-77.
23. Goedert M., Spillantini M. G., Jakes R., Rutherford D. and Crowther R. A. (1989a) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
24. Goedert M., Spillantini M. G., Potier M. C., Ulrich J. and Crowther R. A. (1989b) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein isoforms in human brain. EMBO J. 8, 393-399.
25. Gorath M., Stahnke T., Mronga T., Goldbaum O. and Richter-Landsberg C. (2001) Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 36, 89-101.
26. Gordon-Krajcer W., Yang L. and Ksiezak-Reding H. (2000) Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205. Brain Res. 856, 163-175.
27. Grabowski P. J. and Black D. L. (2001) Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65, 289-308.
28. Guise S., Braguer D., Carles G., Délacourte A. and Briand C. (2001) Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J. Neurosci. Res. 63, 257-267.
29. Haque N., Tanaka T., Iqbal K. and Grundke-Iqbal I. (1999) Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells. Brain Res. 838, 69-77.
30. Himmler A. (1989) Structure of the bovine tau gene: Alternatively spliced transcripts generate a gene family. Mol. Cell. Biol. 9, 1389-1396.
31. Himmler A., Drechsel D., Kirschner M. W. and Martin D. W. (1989) Tau consists of a set of proteins with repreated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9, 1381-1388.
32. Hirokawa N. (1994) Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr. Opin. Cell Biol. 6, 74-81.
33. Hirokawa N. and Takeda S. (1998) Gene targeting studies begin to reveal the function of neurofilament proteins. J. Cell Biol. 143, 1-4.
34. Hutton M., Lendon C. L., Rizzu P. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
35. Ikegami S., Harada A. and Hirokawa N. (2000) Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci. Lett. 279, 129-132.
36. Jiang Z. H. and Wu J. Y. (1999) Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220, 64-72.
37. Johnson G. V., Seubert P., Cox T. M., Motter R., Brown J. P. and Galasko D. (1997) The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68, 430-433.
38. Jones E. G., Hendry S. H., Liu X. B., Hodgins S., Potkin S. G. and Tourtellotte W. W. (1992) A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J. Neurosci. Meth. 44, 133-144.
39. Kempf M., Clement A., Faissner A., Lee G. and Brandt R. (1996) Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J. Neurosci. 16, 5583-5592.
40. Ko H. W., Han K. S., Kim E. Y., Ryu B. R., Yoon W. J., Jung Y. K., Kim S. U. and Gwag B. J. (2000) Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-D-aspartate-induced necrosis in mouse cortical neurons. J. Neurochem. 74, 2455-2461.
41. Kosik K. S., Orecchio L. D., Bakalis S. and Neve R. L. (1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
42. Lee G., Neve R. L. and Kosik K. S. (1989) The microtubule binding domain of tau protein. Neuron 2, 1615-1654.
43. Lee G. and Rook S. L. (1992) Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J. Cell Sci. 102, 227-237.
44. Lee G., Thangavel R., Sharma V., Litersky J., Bhaskar K., Fang S., Do L., Andreadis A., van Hoesen G. and Ksiezak-Reding H. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24, 2304-2312.
45. Liu C. W., Lee G. and Jay D. G. (1999) Tau is required for neurite outgrowth and growth cone motility of chick sensory neurons. Cell Motil. Cytoskel. 43, 232-242.
46. López A. J. (1995) Developmental role of transcription factor isoforms generated by alternative splicing. Dev. Biol. 172, 396-411.
47. LoPresti P., Szuchet S., Papasozomenos S. C., Zinkowski R. P. and Binder L. I. (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92, 10369-10373.
48. Lovestone S. and Reynolds C. H. (1997) The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78, 309-324.
49. Luo M., Leski M. L. and Andreadis A. (2004) Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation. J. Cell. Biochem. 91, 880-895.
50. Mandelkow E. M., Biernat J., Drewes G., Gustke N., Trinczek B. and Mandelkow E. (1995) Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging 16, 355-362; discussion 362-363.
51. Nuñez J. and Fischer I. (1997) Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration. J. Mol. Neurosci. 8, 207-222.
52. Nuydens R., Dispersyn G., de Jong M., van den Kieboom G., Borgers M. and Geerts H. (1997) Aberrant tau phosphorylation and neurite retraction during NGF deprivationin PC12 cells. Biochem. Biophys. Res. Commun. 240, 687-691.
53. Sayas C. L., Moreno-Flores M. T., Avila J. and Wandosell F. (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J. Biol. Chem. 274, 37046-37052.
54. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A. and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741.
55. Uberti D., Rizzini C., Spano P. F. and Memorandum M. (1997) Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line. Neurosci. Lett. 235, 149-153.
56. Wang Y., Loomis P., Zinkowski R. and Binder L. I. (1993) A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J. Cell Biol. 121, 257-267.
57. Wei M. L. and Andreadis A. (1998) Splicing of a regulated exon reveals additional complexity in the axonal microtubule-associated protein tau. J. Neurochem. 70, 1346-1356.
58. Wei M. L., Memmott J., Screaton G. and Andreadis A. (2000) The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron. Brain Res. Mol. Brain Res. 80, 207-218.
59. Zhang J. and Johnson G. V. (2000) Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. J. Neurochem. 75, 2346-2357.
60. Zhao Z., Ho L., Suh J., Qin W., Pyo H., Pompl P., Ksiezak-Reding H. and Pasinetti G. M. (2003) A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol. Cell. Neurosci. 24, 367-379.